Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.255
+0.095 (4.40%)
Dec 16, 2025, 3:21 PM EST - Market open
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $895.16 million as of December 16, 2025. Its market cap has decreased by -68.75% in one year.
Market Cap
895.16M
Enterprise Value
646.85M
1-Year Change
-68.75%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $895.16M, an increase of 265.97%. That is a compound annual growth rate of 12.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 857.50M | -61.98% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |